Healthcare IT & Genomics

Extensive coverage and detailed analysis of healthcare IT and genomics markets. Coverage includes clinical content management IT, imaging IT, archiving & management, digital pathology, advanced visualisation, Ai in drug development, clinical trials, radiation dose management and oncology informatics & diagnostics.

Reports

Structured Reporting Adoption in Imaging IT - World - 2021

This is Signify Research’s 2021 report on the global Structured Reporting Adoption in Imaging IT market.

Find out more

Imaging IT – Core Report - World - 2021

This report provides world market analysis including: Radiology IT (PACS, RIS, EI), Cardiology IT (CVPACS, CVIS, CV-EI), VNA, IE, Advanced Visualisation and Universal Viewing. Full data analysis in 25 country markets.

Find out more

Digital Pathology - World - 2021

This is a proposal for a new market report on the global market for Digital Pathology, to be published in October 2021.

Find out more

Cloud Adoption in Imaging IT - World - 2020

This is a brochure for Signify Research’s report on the global market for Cloud Adoption in Imaging IT – World – 2020, published in May 2021.

Find out more

Imaging IT – Market Intelligence Service - 2020/2021

This Market Intelligence Service is an annual subscription that provides ongoing data, insights and analysis on the global opportunities for Imaging IT.

Find out more

Imaging IT – Core Report - World - 2020

This report provides world market analysis including: Radiology IT (PACS, RIS, EI), Cardiology IT (CVPACS, CVIS, CV-EI), VNA, IE, Advanced Visualisation and Universal Viewing. Full data analysis in 25 country markets.

Find out more

Analyst Insights

Signify Premium Insight: The Key Trends of RSNA 2021: Medical Imaging AI

Signify Premium Insights Subscription Required

26th October 2021 – The RSNA Annual Meeting is rapidly approaching, with vendors soon returning to the Chicago exhibition hall for the first time since 2019. This Premium Insight details the trends and developments that medical imaging AI vendors are set to be promoting at the event.

Signify Premium Insight: Intelerad’s Intent Becomes Clear With Ambra Acquisition

Signify Premium Insights Subscription Required

20th October 2021 – Intelerad has continued its acquisition spree with the purchase of Ambra. Intelerad will gain some valuable capability, but it will have to work to maximise the benefit it gets out of Ambra, and its five other recent acquisitions.

Signify Premium Insight: The Key Trends of RSNA 2021: Imaging IT

Signify Premium Insights Subscription Required

15th October 2021 – The RSNA Annual Meeting is rapidly approaching, with vendors soon returning to the Chicago exhibition hall for the first time since 2019. This Premium Insight details the trends and developments that medical imaging IT vendors are set to be showing off at the event.

Signify Premium Insight: Addressing the Shortcomings of AI

Signify Premium Insights Subscription Required

5th October 2021 – A recent study appeared to dampen the excitement for medical imaging AI after concluding that some breast screening tools were a long way from having the quality or quantity of evidence required for their adoption into clinical practice. This Premium Insight adds context to this verdict and considers the other factors at play.

Signify Premium Insight: Intelerad Adds Insignia to its List of Acquisitions

Signify Premium Insights Subscription Required

16th September 2021 – Intelerad’s acquisition run continues, as Insignia Medical Systems is bought up by the Canadian vendor. The move will help Intelerad progress in the UK market, but, only if it can overcome the issues of integration.